Healthcare Regulatory Affairs Outsourcing Market Size Projected to Reach $17.9 billion by 2034 | 8%

According to Straits Research, the global healthcare regulatory affairs outsourcing market size was valued at $8.95 billion in 2025 and is projected to grow from $9.67 billion in 2026 to $17.9 billion by 2034 at a CAGR of 8% during the forecast period 2026-2034.

The healthcare regulatory affairs outsourcing market’s most prominent drivers are complex regulatory requirements, declining revenues from the lost sales of blockbuster drugs, reduced healthcare costs, and increasing operational costs. Today, several leading regulatory consulting companies are offering their expertise across the complete product life cycle to sustain in the raging competition. Outsourcing of regulatory affairs can be an attractive option for sponsors to gain experience, optimize cost, and enhance productivity. Regulatory outsourcing companies are equipped with real experience and are in a better position to assess regulatory requirements.

The product-specific regulatory advice and strategies, along with healthcare regulatory compliance at the early stages of product development, are essential for product approval. Failure to address the compliance in the early stage of development often leads to delay in the approval process due to inappropriately filed documentation, manufacturing oversights, omitted regulatory studies, and other failures. Healthcare companies are now focusing on their core competencies and outsourcing noncore functions to increase their productivity and operational efficiency. These companies generally outsource regulatory functions to emerging markets, such as the Asia Pacific and MEA to, further driving the market growth

Key Highlights

• The global healthcare regulatory affairs outsourcing market size was valued at $8.95 billion in 2025 and is projected to grow from $9.67 billion in 2026 to $17.9 billion by 2034 at a CAGR of 8% during the forecast period 2026-2034
• The regulatory writing and publishing segment holds the maximum share in the regulatory affairs outsourcing market.
• The pharmaceutical segment holds the largest market share due to the increasing adoption of regulatory affairs outsourcing services and strong competition to get new drug approvals.
• The biotechnology segment is projected to gain momentum due to the growing adoption of outsourcing services for regulatory filings to expand their presence in the healthcare market.

Market Segments

1. By Services
   
   1. Regulatory consulting
   2. Legal representation
   3. Regulatory writing
   4. Publishing
   5. Product Registration
   6. Clinical trial applications
2. By End-User
   
   1. Medical device
   2. Pharmaceutical
   3. Biotechnology
   4. Food and beverages